Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Other GLP-1 receptor agonists include liraglutide and dulaglutide
10.1016/j.joca.2015.04.005 23 HuffmanK
Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025
These GLP-1s include prescription drugs like Ozempic and Wegovy, which have the active ingredient semaglutide, Trulicity, which contains dulaglutide, and Zepbound and Mounjaro which are newer tirzepatides
While Ozempic is effective for managing diabetes, patients should be aware of the risk of allergic reactions
IGF-1 LR3 is sold for laboratory research use only
US$ 23.56
US$ 28.75
US$ 25.12
US$ 27.38
US$ 25.17
